Related Experiment Videos
Interferon effects upon fluorouracil metabolism by HL-60 cells
1Department of Medicine and Cancer Center, University of New Mexico, School of Medicine, Albuquerque 87131.
Biochemical and Biophysical Research Communications
|September 15, 1989
Summary
Interferon enhances the antiproliferative effects of fluorouracil (FUra) by increasing FdUMP accumulation, which sensitizes cancer cells to thymidylate synthase inhibition. This combination therapy shows promise for cancer treatment.
Area of Science:
- Biochemistry
- Pharmacology
- Cancer Research
Background:
- Interferon and fluorouracil (FUra) are used in cancer therapy.
- Understanding their synergistic effects is crucial for optimizing treatment.
- Thymidylate synthase inhibition is a key mechanism of FUra's action.
Purpose of the Study:
- To investigate the synergistic antiproliferative effects of alpha 2-interferon combined with fluorouracil (FUra).
- To elucidate the mechanism by which interferon enhances FUra's inhibition of thymidylate synthase in HL-60 cells.
Main Methods:
- Assessed the 50% inhibitory dose (ID50) of FUra on thymidylate synthase activity in HL-60 cells.
- Measured the effect of alpha 2-interferon pre-treatment on FUra's inhibitory potency.
- Quantified cytosolic [3H]-FdUMP binding and FdUMP/dUMP accumulation in treated cells.
Main Results:
- Interferon treatment significantly reduced the ID50 of FUra from approximately 75 microM to 10 microM.
- Enhanced inhibition of thymidylate synthase and increased FdUMP binding were observed in interferon-treated cells.
- A greater than 10-fold increase in FdUMP accumulation occurred, without a corresponding increase in dUMP.
Conclusions:
- Interferon sensitizes cells to fluorouracil by enhancing the accumulation of FdUMP.
- This mechanism potentiates FUra's inhibition of thymidylate synthase.
- The findings support the synergistic action of interferon and FUra in cancer therapy.